Skip to main content
SpringerLink
Log in
Book cover

Neuro-Psychopharmaka Ein Therapie-Handbuch pp 103–176Cite as

Antiepileptika

  • Chapter

  • 1678 Accesses

Auszug

Antiepileptika entstammen heterogenen Substanzklassen (Tabelle 2.1.1). Ihre Wirksamkeit wurde teils zufällig, teils durch strategische experimentelle Untersuchungen nachgewiesen (siehe Kapitel 2.2).

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Barrett C, Richens A (2003) Epilepsy and pregnancy: report of an epilepsy research foundation workshop. Epilepsy Res 52: 147–187

    Article  PubMed  Google Scholar 

  • Bauer J, Reuber M (2003) Medical treatment of epilepsy. Exp Op Emerg Drugs 8: 457–467

    Article  CAS  Google Scholar 

  • Engel J Jr, Pedley TA (eds) (1997) Epilepsy: a comprehensive textbook. Lippincott-Raven, Philadelphia

    Google Scholar 

  • Fröscher W, Blankenhorn V, May TW et al. (2000) Pharmakotherapie der Epilepsien, 3. Aufl. Schattauer, Stuttgart

    Google Scholar 

  • Kenneth Lloyd G, Gillenwater G (1995) Epilepsy and antiepileptic drugs. In: Munson PL, Mueller RA, Breese GR (eds) Principles of pharmacology. Chapman & Hall, New York, pp 363–398

    Google Scholar 

  • Morrell MJ (2003) Reproductive and metabolic disorders in women with epilepsy. Epilepsia 44[Suppl 4]: 11–20

    Article  PubMed  Google Scholar 

  • Tennis P, Eldridge RR, and the International Lamotrigine Pregnancy Registry Scientific Advisory Committee (2002) Preliminary results on pregnancy outcomes in women using lamotrigine. Epilepsia 43: 1161–1167

    Article  PubMed  CAS  Google Scholar 

Literatur

  • Abdel-Rahman SM, Leeder JS (2000) Phenobarbital, phenytoin, and carbamazepine. In: Levy RH, Thummel KE, Trager WF et al. (eds) Metabolic drug interactions. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  • Anderson GD (2004) Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs. Neurology 63[Suppl 4]: S3–S8

    PubMed  CAS  Google Scholar 

  • Aronson JK, Hardman M (1992) Measuring plasma drug concentrations. BMJ 305: 1078–1080

    PubMed  CAS  Google Scholar 

  • Aronson JK, Hardman M, Reynolds DJM (1992) Phenytoin. BMJ 305: 1215–1218

    PubMed  CAS  Google Scholar 

  • Besag FMC, Berry DJ, Vasey M (2001) Methsuximide reduces valproic acid serum levels. Ther Drug Monit 23: 694–697

    Article  PubMed  CAS  Google Scholar 

  • Brodie MJ, Feely J (1988) Practical clinical pharmacology. Therapeutic drug monitoring and clinical trials. BMJ 296: 1110–1114

    PubMed  CAS  Google Scholar 

  • Contin M, Riva R, Albani F et al. (2002) Topiramate therapeutic monitoring in patients with epilepsy: effect of concomitant antiepileptic drugs. Ther Drug Monit 24: 332–337

    Article  PubMed  CAS  Google Scholar 

  • Contin M, Albani F, Riva R et al. (2004) Levetiracetam therapeutic monitoring in patients with epilepsy. Effect of concomitant antiepileptic drugs. Ther Drug Monit 26: 375–379

    Article  PubMed  CAS  Google Scholar 

  • DeVane CL (2003) Pharmacokinetics, drug interactions, and tolerability of valproate. Psychopharmacol Bull 37[Suppl 2]: 25–42

    PubMed  Google Scholar 

  • Eadie MJ (1997) Neurological diseases. In: Speight TM, Holford NHG (eds) Avery’s drug treatment, 4th edn. Adis International, Auckland

    Google Scholar 

  • Eadie MJ (2001) Therapeutic drug monitoring-antiepileptic drugs. Br J Clin Pharmacol 52: 11S–20S

    Article  PubMed  CAS  Google Scholar 

  • Feely J, Brodie MJ (1988) Practical clinical pharmacology: drug handling and response. BMJ 296: 1046–1050

    PubMed  CAS  Google Scholar 

  • Ferrari AR, Guerrini R, Gatti G et al. (2003) Influence of dosage, age, and co-medication on plasma topiramate concentrations in children and adults with severe epilepsy and preliminary observations on correlations with clinical response. Ther Drug Monit 25: 700–708

    Article  PubMed  CAS  Google Scholar 

  • Flockhart DA (updated 9.11.2004) Drug interaction table. http://medicine.iupui.edu/flockhart/

    Google Scholar 

  • Fröscher W, Krämer G, Schmidt D et al. (1999) Serumkonzentration von Antiepileptika. Praktische Richtlinien zur Messung und sinnvollen Interpretation. Nervenarzt 70: 172–177

    Article  PubMed  Google Scholar 

  • Glue P, Banfield CR, Perhach JL et al. (1997) Pharmacokinetic interactions with felbamate. In vitro-in vivo correlation. Clin Pharmacokinet 33: 214–224

    PubMed  CAS  Google Scholar 

  • Hachad H, Ragueneau-Majlessi I, Levy RH (2002) New antiepileptic drugs: review on drug interactions. Ther Drug Monit 24: 91–103

    Article  PubMed  CAS  Google Scholar 

  • Hirsch LJ, Weintraub D, Du Y et al. (2004) Correlating lamotrigine serum concentrations with tolerability in patients with epilepsy. Neurology 63: 1022–1026

    PubMed  CAS  Google Scholar 

  • Holford NHG, Tett S (1997) Therapeutic drug monitoring: the strategy of target concentration intervention. In: Speight TM, Holford NHG (eds) Avery’s drug treatment, 4th edn. Adis International, Auckland

    Google Scholar 

  • Hung C-C, Lin C-L, Chen C-C et al. (2004) Dosage recommendation of phenytoin for patients with epilepsy with different CYP2C9/CYP2 C19 polymorphisms. Ther Drug Monit 26: 534–540

    Article  PubMed  CAS  Google Scholar 

  • Johannessen SI, Battino D, Berry DJ et al. (2003) Therapeutic drug monitoring of the newer antiepileptic drugs. Ther Drug Monit 25: 347–363

    Article  PubMed  CAS  Google Scholar 

  • Kozer E, Parvez S, Minassian BA et al. (2002) How high can we go with phenytoin? Ther Drug Monit 24: 386–389

    Article  PubMed  CAS  Google Scholar 

  • LEVY RH, THUMMEL KE, TRAGER WF et al. (eds) (2000) Metabolic drug interactions. Lippincott Williams & Wilkins, Philadelphia

    Google Scholar 

  • Mataringa M-I, May TW, Rambeck B (2002) Does lamotrigine influence valproate concentrations? Ther Drug Monit 24: 631–636

    Article  PubMed  CAS  Google Scholar 

  • May TW, Korn-Merker E, Rambeck B (2003a) Clinical pharmacokinetics of oxcarbazepine. Clin Pharmacokinet 42: 1023–1042

    Article  PubMed  CAS  Google Scholar 

  • May TW, Rambeck B, Jürgens U (2002) Serum concentrations of topiramate in patients with epilepsy: influence of dose, age, and comedication. Ther Drug Monit 24: 366–374

    Article  PubMed  CAS  Google Scholar 

  • May TW, Rambeck B, Jürgens U (2003b) Serum concentrations of levetiracetam in epileptic patients: the influence of dose and co-medication. Ther Drug Monit 25: 690–699

    Article  PubMed  CAS  Google Scholar 

  • Mörike K, Eichelbaum M (2000) Grundlagen der Arzneimitteltherapie und pharmakokinetische Grundbegriffe. Internist 41: 328–331

    Article  PubMed  Google Scholar 

  • Patsalos PN (2000) Antiepileptic drug pharmacogenetics. Ther Drug Monit 22: 127–130

    Article  PubMed  CAS  Google Scholar 

  • Patsalos PN, Perucca E (2003a) Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurology 2: 347–356

    Article  PubMed  CAS  Google Scholar 

  • Patsalos PN, Perucca E (2003b) Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurology 2: 473–481

    Article  PubMed  CAS  Google Scholar 

  • Relling MV, Pui C-H, Sandlund JT et al. (2000) Adverse effect of anticonvulsants on efficacy of chemotherapy for acute lymphoblastic leukaemia. Lancet 356: 285–290

    Article  PubMed  CAS  Google Scholar 

  • Reynolds DJM, Aronson JK (1993) Making the most of plasma concentration measurements. BMJ 306: 48–51

    PubMed  CAS  Google Scholar 

  • Sánchez-Alcatraz A, Quintana B, López E et al. (2002) Effect of vigabatrin on the pharmacokinetics of carbamazepine. J Clin Pharm Ther 27: 427–430

    Article  Google Scholar 

  • Sánchez-Alcatraz A, Quintana B, Rodríguez I et al. (1996) Plasma concentrations of vigabatrinin epileptic patients. J Clin Pharm Ther 21: 393–398

    Google Scholar 

  • Stockley IH (ed) (2002) Stockley’s drug interactions, 6th edn. Pharmaceutical Press, London Chicago

    Google Scholar 

  • Taeschner W, Vožeh S (1997) Pharmacokinetic drug data. In: Speight TM, Holford NHG (eds) Avery’s drug treatment, 4th edn. Adis International, Auckland

    Google Scholar 

  • Tanaka E (1999) Clinically significant pharmacokinetic drug interactions between antiepileptic drugs. J Clin Pharm Ther 24: 87–92

    Article  PubMed  CAS  Google Scholar 

  • Thummel KE, Shen DD (2001) Design and optimization of dosage regimens: pharmacokinetic data. In: Hardman JG, Limbird LE, Gilman AG (eds) Goodman & Gilman’s The pharmacological basis of therapeutics, 10th edn. McGraw-Hill, New York

    Google Scholar 

  • Ucar M, Neuvonen M, Luurila H et al. (2004) Carbamazepine markedly reduces serum concentrations of simvastatin and simvastatin acid. Eur J Clin Pharmacol 59: 879–882

    Article  PubMed  CAS  Google Scholar 

Literatur

  • Bialer M, Johannessen SI, Kupferberg HJ et al. (2002) Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI). Epilepsy Res 51: 31–71

    Article  PubMed  CAS  Google Scholar 

  • Löscher W (1989) GABA and the epilepsies. Experimental and clinical considerations. In: Bowery NG, Nisticò G (eds) GABA. Basic research and clinical applications. Pythagora Press, Rome, pp 260–300

    Google Scholar 

  • Löscher W (2002) Current status and future directions in the pharmacotherapy of epilepsy. Trends Pharmacol Sci 23: 113–118

    Article  PubMed  Google Scholar 

  • Löscher W, Potschka H (2002) Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J Pharmacol Exp Ther 301: 7–14

    Article  PubMed  Google Scholar 

  • Löscher W, Schmidt D (1994) Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res 17: 95–134

    Article  PubMed  Google Scholar 

  • Remy S, Gabriel S, Urban BW et al. (2003) A novel mechanism underlying drug resistance in chronic epilepsy. Ann Neurol 53: 469–479

    Article  PubMed  CAS  Google Scholar 

  • Rogawski MA, Löscher W (2004) The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nature Med 10: 685–692

    Article  PubMed  CAS  Google Scholar 

  • Temkin NR (2001) Antiepileptogenesis and seizure prevention trials with antiepileptic drugs: meta-analysis of controlled trials. Epilepsia 42: 515–524

    Article  PubMed  CAS  Google Scholar 

Literatur

  • Bertrand S, Nouel D, Morin F et al. (2003) Gabapentin actions on Kir3 currents and N-type Ca2+ channels via GABAB receptors in hippocampal pyramidal cells. Synapse 50:95–109

    Article  PubMed  CAS  Google Scholar 

  • Bialer M, Johannessen SI, Kupferberg HJ et al. (2002) Progress report on new antiepileptic drugs: a summary of the Sixth Eilat Conference (EILAT VI). Epilepsy Res 51: 31–71

    Article  PubMed  CAS  Google Scholar 

  • Cooper EC (2001) Potassium channels: how genetic studies of epileptic syndromes open paths to new therapeutic targets and drugs. Epilepsia 42[Suppl 5]: 49–54

    Article  PubMed  Google Scholar 

  • Gomora JC, Daud AN, Weiergraber M et al. (2001) Block of cloned human T-type calcium channels by succinimide antiepileptic drugs. Mol Pharmacol 60: 1121–1132

    PubMed  CAS  Google Scholar 

  • Löscher W (1989) GABA and the epilepsies. Experimental and clinical considerations. In: Bowery NG, Nisticò G (eds) GABA. Basic research and clinical applications. Pythagora Press, Rome, pp 260–300

    Google Scholar 

  • Löscher W (2002) Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy. CNS Drugs 16:669–694

    Article  PubMed  Google Scholar 

  • Löscher W, Schmidt D (1994) Strategies in antiepileptic drug development: is rational drug design superior to random screening and structural variation? Epilepsy Res 17: 95–134

    Article  PubMed  Google Scholar 

  • Löscher W, Rogawski MA (2002) Epilepsy. In: Lodge D, Danysz W, Parsons CG (eds) Ionotropic glutamate receptors as therapeutic target. Graham Publ, Johnson City, TN, pp 91–132

    Google Scholar 

  • Margineanu DG, Klitgaard H (2002) Levetiracetam: mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS et al. (eds) Antiepileptic drugs, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 419–427

    Google Scholar 

  • Olsen RW, Delorey TM, Gordey M et al. (1999) GABA receptor function and epilepsy. Adv Neurol 79: 499–510

    PubMed  CAS  Google Scholar 

  • Olsen RW, Avoli M (1997) GABA and epileptogenesis. Epilepsia 38: 399–407

    Article  PubMed  CAS  Google Scholar 

  • Ong J, Kerr DI (2000) Recent advances in GABAB receptors: from pharmacology to molecular biology. Acta Pharmacol Sin 21: 111–123

    PubMed  CAS  Google Scholar 

  • Richards DA, Manning JP, Barnes D et al. (2003) Targeting thalamic nuclei is not sufficient for the full anti-absence action of ethosuximide in a rat model of absence epilepsy. Epilepsy Res 54: 97–107

    Article  PubMed  CAS  Google Scholar 

  • Rogawski MA, Löscher W (2004a) The neurobiology of antiepileptic drugs for the treatment of nonepileptic conditions. Nature Med 10: 685–692

    Article  PubMed  CAS  Google Scholar 

  • Rogawski MA, Löscher W (2004b) The neurobiology of antiepileptic drugs. Nature Rev Neurosci 5: 553–564

    Article  CAS  Google Scholar 

  • Scheffer IE, Berkovic SF (2003) The genetics of human epilepsy. Trends Pharmacol Sci 24:428–433

    Article  PubMed  CAS  Google Scholar 

  • Taylor CP (2002) Gabapentin: mechanisms of action. In: Levy RH, Mattson RH, Meldrum BS et al. (eds) Antiepileptic drugs, 5th edn. Lippincott Williams & Wilkins, Philadelphia, pp 321–334

    Google Scholar 

  • Wickenden AD (2002) Potassium channels as anti-epileptic drug targets. Neuropharmacology 43: 1055–1060

    Article  PubMed  CAS  Google Scholar 

Literatur

  • Aldenkamp AP, Krom MD, Reijs R (2003) Newer antiepileptic drugs and cognitive issues. Epilepsia 44[Suppl 4]: 21–29

    Article  PubMed  CAS  Google Scholar 

  • Barrett C, Richens A (2003) Epilepsy and pregnancy: report of an epilepsy research foundation workshop. Epilepsy Res 52: 147–187

    Article  PubMed  Google Scholar 

  • Bauer J (1996) Seizure-inducing effects of antiepileptic drugs: a review. Acta Neurol Scand 94: 367–377

    PubMed  CAS  Google Scholar 

  • Bauer J (1998) Antiepileptische Kombinationstherapie: Rationale Konzepte versus reelle Effektivität. Fortschr Neurol Psychiat 66: 414–426

    PubMed  CAS  Google Scholar 

  • Bauer J (2002) Epilepsie. Steinkopff, Darmstadt

    Google Scholar 

  • Bauer J, Elger CE (1993) Die akute Valproinsäure-Enzephalopathie. Akt Neurol 20: 16–21

    Google Scholar 

  • Bauer J, Elger CE (1994) Management of status epilepticus in adults. CNS Drugs 1: 26–44

    Google Scholar 

  • Bauer J, Neumann M (2000) Medikamentöse Therapie der chronischen Epilepsie. Nervenheilkunde 19: 533–535

    Google Scholar 

  • Bauer J, Reuber M (2003) Medical treatment of epilepsy. Exp Op Emerg Drugs 8: 457–467

    Article  CAS  Google Scholar 

  • Bauer J, Isojärvi JIT, Herzog AG et al. (2002) Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry 73: 121–125

    Article  PubMed  CAS  Google Scholar 

  • Bauer J, Blumenthal S, Reuber M et al. (2004) Epilepsy syndrome, focus location, and treatment affect testicular function in men with epilepsy. Neurology 62: 243–246

    PubMed  Google Scholar 

  • Beyenburg S, Bauer J, Elger CE (2000) Therapie des generalisierten tonisch-klonischen Status epilepticus im Erwachsenenalter. Nervenarzt 71: 65–77

    Article  PubMed  CAS  Google Scholar 

  • Biton V, Mirza W, Montouris G et al. (2001) Weight change associated with valproate and lamotrigine monotherapy in patients with epilepsy. Neurology 56: 172–177

    Article  PubMed  CAS  Google Scholar 

  • Bourgeois BF (2003) Chronic management of seizures in the syndromes of idiopathic generalized epilepsy. Epilepsia 44[Suppl 2]: S27–32

    Article  Google Scholar 

  • Breum L, Astrup A, Gram L et al. (1992) Metabolic changes during treatment with valproate in humans: implications for untoward weight gain. Metabolism 41: 666–670

    Article  PubMed  CAS  Google Scholar 

  • Brodie MJ (1998) A multicenter double-blind randomized comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsia 39[Suppl 6]: 72

    Google Scholar 

  • Brodie MJ, Chadwick DW, Anhut H et al. (2002) Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy. Epilepsia 43: 993–1000

    Article  PubMed  CAS  Google Scholar 

  • Brunbech L, Sabers A (2002) Effect of antiepileptic drugs on cognitive function in individuals with epilepsy. Drugs 62: 593–604

    Article  PubMed  CAS  Google Scholar 

  • Elger CE, Bauer J (1998) New antiepileptic drugs in epileptology. Neuropsychobiology 38:145–148

    Article  PubMed  CAS  Google Scholar 

  • Elger CE, Fernandez G (1999) Options after the first antiepileptic drug has failed. Epilepsia 40[Suppl 6]: S9–12

    Article  PubMed  CAS  Google Scholar 

  • Elger CE, Bauer J, Scherrmann J et al. (1998) Aggravation of focal epileptic seizures by antiepileptic drugs. Epilepsia 39[Suppl 3]: S15–18

    PubMed  CAS  Google Scholar 

  • French JA, Kanner AM, Bautista J et al. (2004a) Efficacy and tolerability of the new antiepileptic drugs. I. Treatment of new-onset epilepsy: report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 45:401–409

    Article  PubMed  CAS  Google Scholar 

  • French JA, Kanner AM, Bautista J et al. (2004b) Efficacy and tolerability of the new antiepileptic drugs. II. Treatment of refractory epilepsy: report of the TTA and QSS subcommittees of the American Academy of Neurology and the American Epilepsy Society. Epilepsia 45:410–423

    Article  PubMed  CAS  Google Scholar 

  • Herzog AG, Drislane FW, Schomer DL et al. (2004) Differential effects of antiepileptic drugs on sexual function and reproductive hormones in men with epilepsy: interim analysis of a comparison between lamotrigine and enzyme-inducing antiepileptic drugs. Epilepsia 45: 764–768

    Article  PubMed  CAS  Google Scholar 

  • Karceski S, Morrell M, Carpenter D (2001) The expert consensus guideline series. Treatment of epilepsy. Epilepsy Behav 2: A1–A50

    Article  Google Scholar 

  • Kwan P, Brodie MJ (2000) Epilepsy after the first drug fails: substitution or add-on? Seizure 9:464–468

    Article  PubMed  CAS  Google Scholar 

  • Mattson RH, Cramer JA, Collins JF (1992) A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. N Engl J Med 327: 765–771

    Article  PubMed  CAS  Google Scholar 

  • Mattson RH, Cramer JA, Collins JF (1996) Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Neurology 47: 68–76

    PubMed  CAS  Google Scholar 

  • Nicolson A, Appleton RE, Chadwick DW et al. (2004) The relationship between treatment with valproate, lamotrigine, and topiramate and the progosis of the idiopathic generalized epilepsies. J Neurol Neurosurg Psychiatry 75:75–79

    PubMed  CAS  Google Scholar 

  • Treiman DM, Meyers PD, Walton NY et al. (1998) A comparison of four treatments for generalized convulsive status epilepticus. N Engl J Med 339: 792–798

    Article  PubMed  CAS  Google Scholar 

Literatur

  • Bauer J (2002) Epilepsie. Steinkopff, Darmstadt

    Google Scholar 

  • Bauer J (2004) Status epilepticus: Therapie. In: FRÖSCHER W, VASELLA, HUFNAGEL A (Hrsg) Epilepsien. Schattauer, Stuttgart, S 650–657

    Google Scholar 

  • Guberman A, Bruni J (1999) Essentials of clinical epilepsy. Butterworth Heinemann, Boston

    Google Scholar 

  • Schmidt D, Elger CE (2002) Praktische Epilepsiebehandlung. Thieme, Stuttgart

    Google Scholar 

Literatur

  • Barrett C, Richens A (2003) Epilepsy and pregnancy: report of an epilepsy research foundation workshop. Epilepsy Res 52: 147–187

    Article  PubMed  Google Scholar 

  • Bauer J (1996) Seizure-inducing effects of antiepileptic drugs: a review. Acta Neurol Scand 94: 367–377

    Article  PubMed  CAS  Google Scholar 

  • Bauer J (2002) Epilepsie. Steinkopff, Darmstadt

    Google Scholar 

  • Bauer J (2003) Akut-und Langzeitverträglichkeit neuer Antiepileptika. Neurol Psychiat 3: 34–36

    Article  Google Scholar 

  • Bauer J, Schwalen S (2000) Topiramat (Topamax): pharmakologische Charakteristik und Stellenwert in der aktuellen Epilepsietherapie. Nervenarzt 71: 495–501

    Article  PubMed  CAS  Google Scholar 

  • Bauer J, Penin H, Burr W (1988) Nebenerscheinungen unter Valproinsäuretherapie im Erwachsenenalter. Nervenarzt 59: 26–31

    PubMed  CAS  Google Scholar 

  • Bauer J, Hermann A, Reuber M (2002a) Verträglichkeit einer hochdosierten Carbamazepin Monotherapie zur Epilepsiebehandlung. Nervenarzt 73: 533–537

    Article  PubMed  CAS  Google Scholar 

  • Bauer J, Isojärvi JIT, Herzog AG et al. (2002b) Reproductive dysfunction in women with epilepsy: recommendations for evaluation and management. J Neurol Neurosurg Psychiatry 73: 121–125

    Article  PubMed  CAS  Google Scholar 

  • Brodie MJ (1998) A multicenter double-blind randomized comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsia 39[Suppl 6]: 72

    Google Scholar 

  • Dinkelacker V, Dietl T, Widman G et al. (2003) Aggressive behavior of epilepsy patients in the course of levetiracetam add-on therapy: report of 33 severe cases. Epilepsy Behav 4: 537–547

    Article  PubMed  Google Scholar 

  • Ettinger AB, Bernal OG, Andriola MR et al. (1999) Two cases of nonconvulsive status epilepticus in association with tiagabin therapy. Epilepsia 40: 1159–1162

    Article  PubMed  CAS  Google Scholar 

  • Grosse P, Rusch L, Schmitz B (2002) Pancreatitis complicating treatment with intravenous valproic acid. J Neurol 249: 484–485

    Article  PubMed  Google Scholar 

  • Hupperich K, Bauer J (2004) Intoxikation durch neue Antiepileptika. Z Epileptol 17: 1–21

    Article  CAS  Google Scholar 

  • Kockelmann E, Elger CE, Helmstaedter C (2003) Significant improvement in frontal lobe associated neuropsychological functions after withdrawal of topiramate in epilepsy patients. Epilepsy Res 54: 171–178

    Article  PubMed  CAS  Google Scholar 

  • König StA, Elger CE, Vassella F et al. (1988) Empfehlungen zu Blutuntersuchungen und klinischer Überwachung zur Früherkennung des Valproat-assoziierten Leberversagens. Nervenarzt 69: 835–840

    Google Scholar 

  • Luef GJ, Waldmann M, Sturm W et al. (2004) Valproate therapy and nonalcoholic fatty liver disease. Ann Neurol 55: 729–732

    Article  PubMed  CAS  Google Scholar 

  • Masur H, Elger CE, Ludolph AC et al. (1998) Cerebellar atrophy following acute intoxication with phenytoin. Neurology 39: 432–433

    Google Scholar 

  • Mattson RH, Cramer JA, Collins JF (1996) Prognosis for total control of complex partial and secondarily generalized tonic clonic seizures. Neurology 47: 68–76

    PubMed  CAS  Google Scholar 

  • Messenheimer JA, Guberman AH (2000) Rash with lamotrigine: dosing guidelines. Epilepsia 41: 488

    Article  PubMed  CAS  Google Scholar 

  • Schmidt D, Elger CE (2002) Praktische Epilepsiebehandlung. Thieme, Stuttgart

    Google Scholar 

  • Schmitz B, Schmidt T, Jokiel B et al. (2002) Visual field constricition in epilepsy patients treated with vigabatrin and other antiepileptic drugs: a prospective study. J Neurol 249: 469–475

    Article  PubMed  CAS  Google Scholar 

Literatur

  • Beyenburg S, Bauer J, Elger CE (2000) Therapie des generalisierten tonisch-klonischen Status epilepticus im Erwachsenenalter. Nervenarzt 71: 65–77

    Article  PubMed  CAS  Google Scholar 

  • Beyenburg S, Bauer J, Reuber M (2004) New drugs for the treatment of epilepsy: a practical approach. Postgrad Med J 80: 581–587

    Article  PubMed  CAS  Google Scholar 

  • Doose DR, Wang SS, Padmanabhan M et al. (2003) Effect of topiramate or carbamazepine on the pharmacokinetics of an oral contraceptive containing norethindrone and ethinyl estradiol in healthy obese and nonobese female subjects. Epilepsia 44: 540–549

    Article  PubMed  CAS  Google Scholar 

  • LaRoche SM, Helmers SL (2004) The new antiepileptic drugs: scientific review. JAMA 291: 605–614

    Article  PubMed  CAS  Google Scholar 

  • Patsalos PN, Perucca E (2003a) Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs. Lancet Neurol 2: 347–356

    Article  PubMed  CAS  Google Scholar 

  • Patsalos PN, Perucca E (2003b) Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs. Lancet Neurol 2: 473–481

    Article  PubMed  CAS  Google Scholar 

  • Sabers A, Ohman I, Christensen J et al. (2003) Oral contraceptives reduce lamotrigine plasma level. Neurology 61: 570–571

    PubMed  CAS  Google Scholar 

  • Sander JW (2004) The use of antiepileptic drugs. Principles and practice. Epilepsia 45[Suppl 6]: 28–34

    Article  PubMed  Google Scholar 

  • Vecht CJ, Wagner GL, Wilms EB (2003) Interactions between antiepileptic and chemotherapeutic drugs. Lancet Neurol 7: 404–409

    Article  Google Scholar 

Literatur

  • Bauer J (2002) Epilepsie. Steinkopff, Darmstadt

    Google Scholar 

  • Bauer J (2003) Akut-und Langzeitverträglichkeit neuer Antiepileptika. Neurol Psychiat 3: 34–36

    Google Scholar 

  • Bauer J, Penin H, Burr W (1988) Nebenerscheinungen unter Valproinsäuretherapie im Erwachsenenalter. Nervenarzt 59: 26–31

    PubMed  CAS  Google Scholar 

  • Harden CL (2003) Menopause and bone density issues for women with epilepsy. Neurology 61[Suppl 2]: S16–22

    PubMed  Google Scholar 

  • König STA, Elger CE, Vassella F et al. (1998) Empfehlungen zu Blutuntersuchungen und klinischer Überwachung zur Früherkennung des Valproat-assoziierten Leberversagens. Nervenarzt 69: 835–840

    Article  PubMed  Google Scholar 

  • Pack AM, Morrell MJ (2004) Epilepsy and bone health in adults. Epilepsy Behav 5[Suppl 2]: S24–29

    Article  PubMed  Google Scholar 

Literatur

  • Aird RB (1983) The importance of seizure-inducing factors in the control of refractory forms of epilepsy. Epilepsia 24: 567–583

    PubMed  CAS  Google Scholar 

  • Baumgartner C (2001) Allgemeine Behandlungsprinzipien. In: Baumgartner C (Hrsg) Handbuch der Epilepsien. Springer, Wien New York, S 264–309

    Google Scholar 

  • Berlit P (1991) Epilepsien — Hinweise und Ratschläge. VCH Verlagsgesellschaft, Weinheim

    Google Scholar 

  • Brodie MJ, Yuen AWC, 105 Study Group (1997) Lamotrigine substitution study: evidence for synergism with sodium valproate. Epilepsy Res 26: 423–432

    Article  PubMed  CAS  Google Scholar 

  • Dam M, Gram L (1987) Epilepsie — Ratschläge für Betroffene und ihre Angehörigen. Hippokrates, Stuttgart

    Google Scholar 

  • Doose H (1998) Epilepsien im Kindes-und Jugendalter, 11. Aufl. Desitin Arzneimittel GmbH, Hamburg

    Google Scholar 

  • Dworetzky BA, Bromfield EB, Grodstein F et al. (2004) Prospective study of smoking as risk factor for seizures or epilepsy: evidence from the nurse’s health study II. Epilepsia 45[Suppl 7]: 258

    Google Scholar 

  • Fröscher W (2000) Laborwertveränderungen durch Antiepileptika. In: Fröscher W, Blankenhorn V, May TW et al. (Hrsg) Pharmakotherapie der Epilepsien, 3. Aufl. Schattauer, Stuttgart, S 189–217

    Google Scholar 

  • Fröscher W (2004a) Indikationen zur Behandlung. In: Fröscher W, Vassella F, Hufnagel A (Hrsg) Die Epilepsien, 2. Aufl. Schattauer, Stuttgart, S 486–492

    Google Scholar 

  • Fröscher W (2004b) Allgemeine Behandlungsrichtlinien. In: Fröscher W, Vassella F, Hufnagel A (Hrsg) Die Epilepsien, 2. Aufl. Schattauer, Stuttgart, S 495–498

    Google Scholar 

  • Frucht MM, Quigg M, Schwaner C et al. (2000) Distribution of seizure precipitants among epilepsy syndromes. Epilepsia 41: 1534–1539

    Article  PubMed  CAS  Google Scholar 

  • Greenberg RN (1984) Overview of patient compliances. Clin Ther 6: 592–599

    PubMed  CAS  Google Scholar 

  • Hauser WA, Rich SS, Lee JR et al. (1998) Risk of recurrent seizures after two unprovoked seizures. N Engl J Med 338: 429–434

    Article  PubMed  CAS  Google Scholar 

  • Höppener RJ, Kuyer A, Van Der Lugt PJM (1983) Epilepsy and alcohol: influence of social alcohol intake on seizures and treatment in epilepsy. Epilepsia 24: 459–471

    PubMed  Google Scholar 

  • Kotagal P (2001) The relationship between sleep and epilepsy. Semin Pediatr Neurol 8: 241–250

    Article  PubMed  CAS  Google Scholar 

  • Kotchoubey B, Strehl U, Uhlmann C et al. (2001) Modification of slow cortical potentials in patients with refractory epilepsy: a controlled outcome study. Epilepsia 42: 406–416

    Article  PubMed  CAS  Google Scholar 

  • Krämer G (2000) Epilepsie: Antworten auf die häufigsten Fragen, 2. Aufl. TRIAS, Thieme, Stuttgart

    Google Scholar 

  • Leppik IE (1988) Compliance during treatment of epilepsy. Epilepsia 29[Suppl 2]: S79–S84

    PubMed  Google Scholar 

  • Matthes H, Schneble H (1999) Diagnostik und Therapie für Klinik und Praxis, 6. Aufl. Thieme, Stuttgart New York

    Google Scholar 

  • Mattson RH (1988) The association of seizures with alcohol use. Epilepsia 29: 494

    Google Scholar 

  • Niedermeyer E (1990) The epilepsies. Urban und Schwarzenberg, München Baltimore

    Google Scholar 

  • Rabending G, Runge U (2004) Computergestützte Dokumentation. In: Fröscher W, Vassella F, Hufnagel A (Hrsg) Die Epilepsien, 2. Aufl. Schattauer, Stuttgart, S 752–757

    Google Scholar 

  • Schmidt D (1993) Epilepsien und epileptische Anfälle. Thieme, Stuttgart New York

    Google Scholar 

  • Takahashi Y, Sato T, Goto K et al. (2001) Optical filters inhibiting television-induced photosensitive seizures. Neurology 57: 1767–1773

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. FRCP, Klinik für Epileptologie, Universität Bonn, Sigmund-Freud-Straße 25, 53105, Bonn, Deutschland

    Ch. E. Elger (Prof. Dr. med.)

  2. Klinik für Epileptologie, Universität Bonn, Sigmund-Freud-Straße 25, 53105, Bonn, Deutschland

    J. Bauer (Prof. Dr. med.)

  3. Institut für Pharmakologie, Toxikologie und Pharmazie, Tierärztliche Hochschule und Zentrum für Systemische Neurowissenschaften, Bünteweg 17, 30559, Hannover, Deutschland

    W. Löscher (Prof. Dr. med. vet.)

Authors
  1. Ch. E. Elger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. Bauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. W. Löscher
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinische Neurochemie, Klinik und Poliklinik für Psychiatrie und Psychotherapie, Universität Würzburg, Deutschland

    Peter Riederer

  2. Bezirksklinikum Gabersee Fachkrankenhaus für Psychiatrie, Psychotherapie, Psychosomatische Medizin und Neurologie, Akademisches Lehrkrankenhaus der Ludwig-Maximilians-Universität München, Wasserburg/Inn, Deutschland

    Gerd Laux

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer-Verlag/Wien

About this chapter

Cite this chapter

Elger, C.E., Bauer, J., Löscher, W. (2006). Antiepileptika. In: Riederer, P., Laux, G. (eds) Neuro-Psychopharmaka Ein Therapie-Handbuch. Springer, Vienna. https://doi.org/10.1007/3-211-37774-3_2

Download citation

  • DOI: https://doi.org/10.1007/3-211-37774-3_2

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-22956-9

  • Online ISBN: 978-3-211-37774-1

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation